EP1173456A4 - Secreted proteins and nucleic acids encoding them - Google Patents

Secreted proteins and nucleic acids encoding them

Info

Publication number
EP1173456A4
EP1173456A4 EP00912073A EP00912073A EP1173456A4 EP 1173456 A4 EP1173456 A4 EP 1173456A4 EP 00912073 A EP00912073 A EP 00912073A EP 00912073 A EP00912073 A EP 00912073A EP 1173456 A4 EP1173456 A4 EP 1173456A4
Authority
EP
European Patent Office
Prior art keywords
nucleic acids
acids encoding
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00912073A
Other languages
German (de)
French (fr)
Other versions
EP1173456A1 (en
Inventor
Thomas M Barnes
Douglas A Holtzman
John D Sharp
Christopher C Fraser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1173456A1 publication Critical patent/EP1173456A1/en
Publication of EP1173456A4 publication Critical patent/EP1173456A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00912073A 1999-03-01 2000-03-01 Secreted proteins and nucleic acids encoding them Withdrawn EP1173456A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12245899P 1999-03-01 1999-03-01
US122458P 1999-03-01
PCT/US2000/005226 WO2000052022A1 (en) 1999-03-01 2000-03-01 Secreted proteins and nucleic acids encoding them

Publications (2)

Publication Number Publication Date
EP1173456A1 EP1173456A1 (en) 2002-01-23
EP1173456A4 true EP1173456A4 (en) 2005-10-12

Family

ID=22402831

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00912073A Withdrawn EP1173456A4 (en) 1999-03-01 2000-03-01 Secreted proteins and nucleic acids encoding them

Country Status (5)

Country Link
EP (1) EP1173456A4 (en)
JP (1) JP2002539773A (en)
AU (1) AU3386800A (en)
CA (1) CA2362924A1 (en)
WO (1) WO2000052022A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073454A1 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030060407A1 (en) 1997-06-16 2003-03-27 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
PT1247863E (en) * 1998-08-11 2006-05-31 Genentech Inc HOMOLOGO OF PROTEIN A OF COBRA POISON AND NUCLEIC ACID THAT CODES IT
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
EP1155117A4 (en) * 1998-12-30 2003-05-14 Millennium Pharm Inc Secreted proteins and nucleic acids encoding them
GB2370840A (en) * 1999-09-16 2002-07-10 Univ Mcgill Nrage nucleic acids and polypeptides and uses thereof
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
WO2002006483A1 (en) * 2000-07-18 2002-01-24 Takeda Chemical Industries, Ltd. Novel physiologically active peptide and use thereof
EP1311547A2 (en) * 2000-08-22 2003-05-21 The Brigham And Women's Hospital, Inc. Diagnosis and treatment of cardiovascular conditions
WO2002031143A2 (en) * 2000-10-12 2002-04-18 The Texas A & M University System Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use
WO2002036762A1 (en) * 2000-10-30 2002-05-10 Takeda Chemical Industries, Ltd. Process for producing peptide
AU2002230778A1 (en) * 2000-11-03 2002-05-15 The Regents Of The University Of California Prokineticin polypeptides, related compositions and methods
EP1506971A1 (en) * 2000-11-03 2005-02-16 The Regents of the University of California Prokineticin polypeptides, related compositions and methods
WO2002057443A1 (en) * 2001-01-22 2002-07-25 Takeda Chemical Industries, Ltd. Process for producing zaq ligand
US20040072293A1 (en) * 2001-02-02 2004-04-15 Tetsuya Ohtaki Novel physiologically active peptide and use thereof
US20040048314A1 (en) * 2001-02-02 2004-03-11 Tetsuya Ohtaki Novel physiologically active peptide and use thereof
EP1357973B1 (en) * 2001-02-09 2008-08-20 Serono Genetics Institute S.A. Gssp4 polynucleotides and polypeptides and uses thereof
DE60328979D1 (en) 2002-05-10 2009-10-08 Jackson H M Found Military Med ANDROGEN-REGULATED PMEPA1 GENE AND METHOD FOR ITS USE TO INHIBIT CANCER GROWTH
WO2004032851A2 (en) 2002-10-04 2004-04-22 The Regents Of The University Of California Screening and therapeutic methods relating to neurogenesis
WO2004052277A2 (en) 2002-12-05 2004-06-24 Wisconsin Alumni Research Foundation Anthrax antitoxins
EP2526960A1 (en) 2003-03-12 2012-11-28 Genentech, Inc. Use of BV8 and/or EG-VEGF to promote hematopoiesis
WO2007130627A2 (en) 2006-05-04 2007-11-15 The Brigham And Women's Hospital, Inc. Il-33 in the treatment and diagnosis of diseases and disorders
PE20120341A1 (en) 2008-12-09 2012-04-24 Genentech Inc ANTI-PD-L1 ANTIBODIES AND ITS USE TO IMPROVE T-CELL FUNCTION

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CELIKEL R ET AL: "CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB", NATURE STRUCTURAL BIOLOGY, NEW YORK, NY, US, vol. 5, no. 3, March 1998 (1998-03-01), pages 189 - 194, XP009003102, ISSN: 1072-8368 *
DATABASE Geneseq [online] 17 June 2004 (2004-06-17), "Human cDNA #807.", XP002325357, retrieved from EBI Database accession no. ADI31481 *
JENKINS P V PASI K J PERKINS S J: "Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 91, no. 6, 15 March 1998 (1998-03-15), pages 2032 - 2044, XP002959883, ISSN: 0006-4971 *
MAEDA K ET AL: "Analysis of an expression profile of genes in the human adipose tissue", GENE, ELSEVIER, AMSTERDAM, NL, vol. 190, 1997, pages 227 - 235, XP002136672, ISSN: 0378-1119 *
See also references of WO0052022A1 *

Also Published As

Publication number Publication date
CA2362924A1 (en) 2000-09-08
AU3386800A (en) 2000-09-21
WO2000052022A1 (en) 2000-09-08
EP1173456A1 (en) 2002-01-23
JP2002539773A (en) 2002-11-26

Similar Documents

Publication Publication Date Title
EP1173456A4 (en) Secreted proteins and nucleic acids encoding them
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1218411A4 (en) Secreted proteins and uses thereof
EP1242443A4 (en) Novel nucleic acids and polypeptides
IL139686A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6802801A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6531101A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL188579A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1661002A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL141535A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1155117A4 (en) Secreted proteins and nucleic acids encoding them
AU2002367815A8 (en) Novel nucleic acids and secreted polypeptides
AU6280899A (en) Secreted proteins and nucleic acids encoding them
AU8308901A (en) Novel proteins and nucleic acids encoding same
AU1181802A (en) Novel proteins and nucleic acids encoding same
EP1383533A4 (en) Proteins and nucleic acids encoding same
EP1189938A4 (en) Secreted proteins and uses thereof
EP1179000A4 (en) Secreted proteins and uses thereof
KR100514265B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
AU3099402A (en) Novel proteins and nucleic acids encoding same
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
EP1492807A4 (en) Novel proteins and nucleic acids encoding same
EP1159413A4 (en) Secreted proteins and uses thereof
KR100528420B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010912

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050902

17Q First examination report despatched

Effective date: 20051025

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070823